Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 McGlynn, 2015, Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability, Clin Liver Dis, 19, 223, 10.1016/j.cld.2015.01.001 Ferre, 2006, Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases, J Hepatol, 45, 51, 10.1016/j.jhep.2005.12.018 Ahmadian, 2016, Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention, Expert Rev Gastroenterol Hepatol, 10, 1279, 10.1080/17474124.2016.1207523 Simoes, 2017, Renin angiotensin system in liver diseases: friend or foe?, World J Gastroenterol, 23, 3396, 10.3748/wjg.v23.i19.3396 Hirose, 2007, Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis, Hepatology, 45, 1375, 10.1002/hep.21638 Yoshiji, 2002, Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor, Tumour Biol, 23, 348, 10.1159/000069792 Dhanasekaran, 2016, Clinical implications of basic research in hepatocellular carcinoma, J Hepatol, 64, 736, 10.1016/j.jhep.2015.09.008 Berretta, 2016, Angiogenesis inhibitors for the treatment of hepatocellular carcinoma, Front Pharmacol, 7, 428, 10.3389/fphar.2016.00428 Pinter, 2017, Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma, United Eur Gastroenterol J, 5, 987, 10.1177/2050640617695698 Barone, 2019, Systematic review: renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma, World J Gastroenterol, 25, 2524, 10.3748/wjg.v25.i20.2524 Yoshiji, 2007, Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases, Curr Med Chem, 14, 2749, 10.2174/092986707782360169 Saber, 2018, Liver protective effects of renin-angiotensin system inhibition have no survival benefits in hepatocellular carcinoma induced by repetitive administration of diethylnitrosamine in mice, Open Access Maced J Med Sci, 6, 955, 10.3889/oamjms.2018.167 Du, 2013, Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo, PLoS One, 8, 10.1371/journal.pone.0083754 Yoshiji, 2009, Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma, J Hepatol, 51, 315, 10.1016/j.jhep.2009.04.011 Lee, 2017, Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea, Int J Epidemiol, 46 Kim, 2018, Bidirectional association between gastroesophageal reflux disease and depression: two different nested case-control studies using a national sample cohort, Sci Rep, 8, 11748, 10.1038/s41598-018-29629-7 Seo, 2018, Rehabilitation therapy utilization in patients with Parkinson’s disease in Korea, Parkinsons Dis, 2018 Seong, 2017, Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea, BMJ Open, 7, 10.1136/bmjopen-2017-016640 WHO Collaborating Centre for Drug Statistic Methodology, 2003 Lee, 2016, Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database, Ther Clin Risk Manag, 12, 1533, 10.2147/TCRM.S117150 Austin, 2010, Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score, Am J Epidemiol, 172, 1092, 10.1093/aje/kwq224 Ye, 2015, The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma, Biochem Biophys Res Commun, 459, 18, 10.1016/j.bbrc.2015.02.030 Saber, 2018, Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B, Toxicol Lett, 295, 32, 10.1016/j.toxlet.2018.05.036 Facciorusso, 2015, Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients, J Gastroenterol Hepatol, 30, 1643, 10.1111/jgh.12988 Ino, 2006, Manipulating the angiotensin system—new approaches to the treatment of solid tumours, Expert Opin Biol Ther, 6, 243, 10.1517/14712598.6.3.243 Fischer, 2002, Renin angiotensin system and gender differences in the cardiovascular system, Cardiovasc Res, 53, 672, 10.1016/S0008-6363(01)00479-5 Feldmer, 1991, Glucocorticoid- and estrogen-responsive elements in the 5’-flanking region of the rat angiotensinogen gene, J Hypertens, 9, 1005, 10.1097/00004872-199111000-00005 O’Donnell, 2014, Estrogen status and the renin angiotensin aldosterone system, Am J Physiol Regul Integr Comp Physiol, 307, R498, 10.1152/ajpregu.00182.2014 Suganuma, 2005, Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination, Clin Cancer Res, 11, 2686, 10.1158/1078-0432.CCR-04-1946 Ribeiro-Oliveira, 2008, The renin-angiotensin system and diabetes: an update, Vasc Health Risk Manag, 4, 787, 10.2147/VHRM.S1905 Oura, 2017, Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest, Oncol Rep, 38, 2825, 10.3892/or.2017.5977 Mansour, 2011, Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver, Life Sci, 89, 188, 10.1016/j.lfs.2011.06.002